GetTopicDetailResponse(id=32f636e2a8, topicName=BRAF突變晚期黑色素瘤, introduction=BRAF突變晚期黑色素瘤, content=null, image=null, comments=1, allHits=1312, url=https://h5.medsci.cn/topic?id=3672, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=4132, tagList=[TagDto(tagId=4132, tagName=BRAF突變晚期黑色素瘤)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2211911, encodeId=8d092211911dc, content=<a href='/topic/show?id=32f636e2a8' target=_blank style='color:#2F92EE;'>#BRAF突變晚期黑色素瘤#</a> <a href='/topic/show?id=4b0e60250e2' target=_blank style='color:#2F92EE;'>#曲美替尼#</a> <a href='/topic/show?id=578993933d0' target=_blank style='color:#2F92EE;'>#達(dá)拉非尼#</a>, objectTitle=NEJM | COMBI-AD 試驗(yàn)最終結(jié)果：達(dá)拉非尼聯(lián)合曲美替尼輔助治療 BRAF 突變的 III 期黑色素瘤, objectType=article, longId=831959, objectId=160e8319593c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240626/1719417009455_6145188.png, objectUrl=/article/show_article.do?id=160e8319593c, replyNumber=0, likeNumber=91, createdTime=2024-06-27, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=160e8319593c, moduleTitle=NEJM | COMBI-AD 試驗(yàn)最終結(jié)果：達(dá)拉非尼聯(lián)合曲美替尼輔助治療 BRAF 突變的 III 期黑色素瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=160e8319593c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1598483, encodeId=23bf159848392, content=<a href='/topic/show?id=32f636e2a8' target=_blank style='color:#2F92EE;'>#BRAF突變晚期黑色素瘤#</a>, objectTitle=AACR 2020：靶向聯(lián)合免疫治療顯著延長(zhǎng)BRAF突變晚期黑色素瘤患者無(wú)進(jìn)展生存（IMspire150試驗(yàn)）, objectType=article, longId=193346, objectId=688d193346bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=688d193346bb, replyNumber=0, likeNumber=134, createdTime=2020-05-03, rootId=0, userName=jiadan198788, userId=569918610703, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=688d193346bb, moduleTitle=AACR 2020：靶向聯(lián)合免疫治療顯著延長(zhǎng)BRAF突變晚期黑色素瘤患者無(wú)進(jìn)展生存（IMspire150試驗(yàn)）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=688d193346bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
